In yesterday’s Wall Street session, Poseida Therapeutics Inc (NASDAQ:PSTX) shares traded at $9.33, down -0.53% from the previous session.
PSTX stock price is now 208.86% away from the 50-day moving average and 210.02% away from the 200-day moving average. The market capitalization of the company currently stands at $904.50M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $15, H.C. Wainwright recently initiated with Buy rating for Poseida Therapeutics Inc (NASDAQ: PSTX). On January 07, 2022, Cantor Fitzgerald recently initiated its ‘Overweight’ rating on the stock quoting a target price of $24, while ‘BTIG Research’ rates the stock as ‘Buy’
In other news, Gergen Mark J, Executive Chairman sold 30,000 shares of the company’s stock on Nov 26 ’24. The stock was sold for $278,100 at an average price of $9.27. Upon completion of the transaction, the Executive Chairman now directly owns 651,291 shares in the company, valued at $6.08 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 26 ’24, Director MARK GERGEN bought 120,000 shares of the business’s stock. A total of $343,200 was incurred on buying the stock at an average price of $2.86. A total of 30.45% of the company’s stock is owned by insiders.
During the past 12 months, Poseida Therapeutics Inc has had a low of $1.87 and a high of $9.41. As of last week, the company has a debt-to-equity ratio of 0.95, a current ratio of 3.20, and a quick ratio of 3.20. The fifty day moving average price for PSTX is $2.9044 and a two-hundred day moving average price translates $2.981075 for the stock.
The latest earnings results from Poseida Therapeutics Inc (NASDAQ: PSTX) was released for 2024-09-30. The net profit margin was -40.28% and return on equity was -57.63% for PSTX. The company reported revenue of $71.75 million for the quarter, compared to $9.35 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 667.19 percent.
